FDA recalls over 200,000 duloxetine bottles due to N-nitroso-duloxetine contamination, increasing cancer risk.

Knowing how to transition from SSRIs to SNRIs will help you better control your symptoms and enhance the results of your ...

Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are two of the most common types of medications used to treat conditions such as depression, ...

For nearly 20 years, antidepressants have carried suicide risk warnings for young people. Now, experts are questioning if the ...

A popular antidepressant, often known by the brand name Cymbalta, was recalled last week due to the presence of a potentially ...

Hormone therapy saves lives, but its hidden costs—sleepless nights, crippling anxiety, and intimacy struggles—leave breast ...

PTSD is a serious mental health condition marked by changes in mood, intrusive memories, avoidant behavior, and a heightened ...

Over 200,000 bottles of the antidepressant duloxetine have been recalled due to higher-than-acceptable levels of ...

Desvenlafaxine (O-desmethylvenlafaxine) is the active metabolite of venlafaxine (Effexor). Prior reports have confirmed venlafaxine use resulting in a false-positive for PCP on a UDS. However, there ...

This was an open, pilot study of escitalopram in patients with MDD who had not responded to treatment with citalopram (clinicaltrials.gov identifier: NCT00785434). Patients meeting the entry ...

SSRI withdrawal: Tapering off an SSRI to switch to an SNRI can lead to withdrawal symptoms like dizziness, nausea, ...